Novartis
News and Video Search Results
News coverage
-
Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire
-
Global Uveitis Treatment Research Report 2024: Market to Reach $1.34 Billion by 2034, Fueled by Increased Prevalence, Treatment Improvements, and Strategic Alliances & Collaborations
GlobeNewswire
-
mHealth Apps Market Size, Share & Trends Analysis Report 2024, with Case Studies of Kilkari, Momconnect, Jhpiego and MPower
GlobeNewswire
-
Temedica expands its Advisory Board with former Gematik CEO Markus Leyck Dieken
EQS Group
0 shares
1 views
You might like
Novartis media coverage
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
GlobeNewswire
LEXINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to..
-
Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
GlobeNewswire
-
JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics
GlobeNewswire
-
Topical Drug Delivery Market Size to Hit USD 229.91 Bn by 2031
GlobeNewswire
-
RNAi Therapeutics Market Size Expected to Reach USD 4.28 Bn by 2033
GlobeNewswire
Advertisement
More coverage
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
GlobeNewswire
· Primary results of the Scemblix^® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA..
-
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
GlobeNewswire
-
Global Engineered T Cells Market Forecast to 2028: Expansion into Solid Tumor Treatment, Advanced Combination Therapies, and Precision Gene-Edited T Cell Therapies
GlobeNewswire
-
Global Oncolytic Virotherapy Market Research 2024: Industry Size, Share, Trends, Opportunity & Forecasts, 2019-2029 - Focus on Personalized Medicine, Clinical Advancements Spurs Growth
GlobeNewswire
-
XEALTH CLIENT THOUGHT LEADERS AT REUTERS EVENTS DIGITAL HEALTH 2024
GlobeNewswire